AZN.UK

10,362

+0.33%↑

GSK

1,429

+1.28%↑

INDV

1,099

-1.7%↓

AZN.UK

10,362

+0.33%↑

GSK

1,429

+1.28%↑

INDV

1,099

-1.7%↓

AZN.UK

10,362

+0.33%↑

GSK

1,429

+1.28%↑

INDV

1,099

-1.7%↓

AZN.UK

10,362

+0.33%↑

GSK

1,429

+1.28%↑

INDV

1,099

-1.7%↓

AZN.UK

10,362

+0.33%↑

GSK

1,429

+1.28%↑

INDV

1,099

-1.7%↓

Search

Oxford Biomedica PLC

Cerrado

347 1.02

Resumen

Variación precio

24h

Actual

Mínimo

320.5

Máximo

354

Métricas clave

By Trading Economics

Ingresos

-11M

Ventas

78M

BPA

-0.077

Margen de beneficio

-13.726

Empleados

850

EBITDA

5M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+19756.37% upside

Dividendos

By Dow Jones

Próximas Ganancias

22 sept 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

356M

Apertura anterior

345.98

Cierre anterior

347

Oxford Biomedica PLC Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

8 jul 2025, 19:37 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

M3-Brigade Shares Fall on Merger With ReserveOne

8 jul 2025, 23:45 UTC

Charlas de Mercado

Gold Edges Lower, Weighed by Higher Treasury Yields -- Market Talk

8 jul 2025, 23:42 UTC

Charlas de Mercado

Nikkei May Rise as Yen Weakens -- Market Talk

8 jul 2025, 23:27 UTC

Charlas de Mercado

Australian REITs Yet to Offer Enough Appeal -- Market Talk

8 jul 2025, 23:27 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

8 jul 2025, 23:21 UTC

Charlas de Mercado

Summerset Bull Lauds Strong 2Q Sales Volumes -- Market Talk

8 jul 2025, 23:21 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

8 jul 2025, 22:29 UTC

Adquisiciones, fusiones, absorciones

Capricorn to Pay A$1.5 Million in Cash and Shares

8 jul 2025, 22:28 UTC

Adquisiciones, fusiones, absorciones

Capricorn Metals Enters Binding Agreement to Buy Claw Gold Project

8 jul 2025, 21:58 UTC

Charlas de Mercado

Kura Sushi Closely Watching U.S. Tariff Negotiations on Asian Goods -- Market Talk

8 jul 2025, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

8 jul 2025, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

8 jul 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

8 jul 2025, 20:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

8 jul 2025, 19:53 UTC

Charlas de Mercado

Copper Posts Biggest One-Day Gain Ever to Hit Record on Tariff Chatter -- Market Talk

8 jul 2025, 19:53 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

8 jul 2025, 19:45 UTC

Charlas de Mercado

Canada Unlikely to Succeed in Bid for Tariff-Free Trade With U.S. -- Market Talk

8 jul 2025, 19:29 UTC

Charlas de Mercado

U.S. Consumer-Credit Growth Slowed in May -- Market Talk

8 jul 2025, 19:20 UTC

Charlas de Mercado

U.S. Natural Gas Futures Settle Lower -- Market Talk

8 jul 2025, 19:11 UTC

Charlas de Mercado

Bank of Canada's Rate Cuts Deliver Muted Relief Along the Curve -- Market Talk

8 jul 2025, 19:01 UTC

Charlas de Mercado

Oil Futures Gain With Support From Products -- Market Talk

8 jul 2025, 18:49 UTC

Ganancias

Hershey Names New CEO, Continuing Leadership Shuffle. The Stock Falls. -- Barrons.com

8 jul 2025, 18:41 UTC

Charlas de Mercado

Mexico's Inflation Seen Mixed in June -- Market Talk

8 jul 2025, 18:38 UTC

Charlas de Mercado

Gold Falls as Markets Digest Details of Trump Tariffs -- Market Talk

8 jul 2025, 18:23 UTC

Charlas de Mercado

Analysts Anticipate Lower Ethanol Inventories -- Market Talk

8 jul 2025, 18:10 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

8 jul 2025, 18:10 UTC

Charlas de Mercado

Freeport-McMoRan Jumps on Trump Tariff Plan for Copper Imports -- Market Talk

8 jul 2025, 17:24 UTC

Charlas de Mercado

Election, Dollar Seen as Potential Headwinds for Ibovespa -- Market Talk

8 jul 2025, 17:06 UTC

Charlas de Mercado

KeyCorp and Regional Banks Set for a Catchup -- Market Talk

8 jul 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Oxford Biomedica PLC Esperado

Precio Objetivo

By TipRanks

19756.37% repunte

Estimación a 12 meses

Media 683.059 GBX  19756.37%

Máximo 800 GBX

Mínimo 566 GBX

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Oxford Biomedica PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

2

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Oxford Biomedica PLC

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.